ResearcherSapporo Medical UniversityActive in the last 2 years

Makoto Osanai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1754-252X; OpenAlex author ID A5071632526. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 10

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Masafumi Imamura · 2 shared papers, 2025–2026 · strength 0.56
- Paper Concordance of claudin-18.2 expression in biopsy, resection, and recurrent specimens: implications for zolbetuximab the… DOI 10.1080/21688370.2025.2535047 ↗
- Paper The Role of Claudin-1 in Enhancing Pancreatic Cancer Aggressiveness and Drug Resistance via Metabolic Pathway Modulatio… DOI 10.3390/cancers17091469 ↗
Daisuke Kyuno · 2 shared papers, 2025–2026 · strength 0.56
- Paper Concordance of claudin-18.2 expression in biopsy, resection, and recurrent specimens: implications for zolbetuximab the… DOI 10.1080/21688370.2025.2535047 ↗
- Paper The Role of Claudin-1 in Enhancing Pancreatic Cancer Aggressiveness and Drug Resistance via Metabolic Pathway Modulatio… DOI 10.3390/cancers17091469 ↗
Tatsuya Ito · 1 shared paper, 2026 · strength 0.33
- Paper Concordance of claudin-18.2 expression in biopsy, resection, and recurrent specimens: implications for zolbetuximab the… DOI 10.1080/21688370.2025.2535047 ↗
Akira Takasawa · 2 shared papers, 2016–2025 · strength 0.28
- Paper The Role of Claudin-1 in Enhancing Pancreatic Cancer Aggressiveness and Drug Resistance via Metabolic Pathway Modulatio… DOI 10.3390/cancers17091469 ↗
- Paper Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer. DOI 10.1038/srep33582 ↗
Takashi Kojima · 2 shared papers, 2016–2025 · strength 0.28
- Paper The Role of Claudin-1 in Enhancing Pancreatic Cancer Aggressiveness and Drug Resistance via Metabolic Pathway Modulatio… DOI 10.3390/cancers17091469 ↗
- Paper Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer. DOI 10.1038/srep33582 ↗
Yasutoshi Kimura · 1 shared paper, 2025 · strength 0.22
- Paper The Role of Claudin-1 in Enhancing Pancreatic Cancer Aggressiveness and Drug Resistance via Metabolic Pathway Modulatio… DOI 10.3390/cancers17091469 ↗
Takumi Konno · 1 shared paper, 2025 · strength 0.22
- Paper The Role of Claudin-1 in Enhancing Pancreatic Cancer Aggressiveness and Drug Resistance via Metabolic Pathway Modulatio… DOI 10.3390/cancers17091469 ↗
Norimasa Sawada · 1 shared paper, 2016 · strength 0.05
- Paper Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer. DOI 10.1038/srep33582 ↗
Koichi Hirata · 1 shared paper, 2016 · strength 0.05
- Paper Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer. DOI 10.1038/srep33582 ↗
Tsuyoshi Kono · 1 shared paper, 2016 · strength 0.05
- Paper Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer. DOI 10.1038/srep33582 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.